Susceptibility to malaria as a complex trait: Big pressure from a tiny creature

Human Molecular Genetics

Volumn 11, Issue 20, 2002, Pages 2469-2478

  Fortin, A ^a   Stevenson, M M ^a   Gros, P ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPORTER; CELL PROTEIN; CHEMOKINE RECEPTOR; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLYCOPHORIN C; MALARIA VACCINE;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DISEASE COURSE; ENDEMIC DISEASE; ERYTHROCYTE; EXPERIMENTAL INFECTION; FEMALE; GENE MAPPING; GENE SEGREGATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; HEREDITY; HOST PARASITE INTERACTION; HUMAN; INFECTION RESISTANCE; LINKAGE ANALYSIS; MALARIA; MOUSE; NONHUMAN; PLASMODIUM MALARIAE; PLEIOTROPY; POPULATION GENETICS; PRIORITY JOURNAL; REVIEW; STRAIN DIFFERENCE;

ANIMALIA; PLASMODIUM; PLASMODIUM MALARIAE; PROTOZOA;

EID: 0036798008     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.20.2469     Document Type: Review

References (124)

1. Greenwood, B. and Mutabingwa, T. (2002) Malaria in 2002. Nature, 415, 670-672.
2. www.who.ch.
3. Richie, T.L. and Saul, A. (2002) Progress and challenges for malaria vaccines. Nature, 415, 694-701.
4. Hill, A.V. (1998) The immunogenetics of human infectious diseases. Annu. Rev. Immunol., 16, 593-617.
5. Yagmur, Y., Kara, I.H., Aldemir, M., Buyukbayram, H., Tacyildiz, I.H. and Keles, C. (2000) Spontaneous rupture of malarial spleen: two case reports and review of literature. Crit. Care, 4, 309-313.
6. Tishkoff, S.A., Varkonyi, R., Cahinhinan, N., Abbes, S., Argyropoulos, G., Destro-Bisol, G., Drousiotou, A., Dangerfield, B., Lefranc, G., Loiselet, J. et al. (2001) Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science, 293, 455-462.
7. Weatherall, D.J. (2001) Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat. Rev. Genet., 2, 245-255.
8. Haldane, J.B.S. (1948) The rate of mutation of human genes, Proceedings of the Eighth International Congress of Genetics and Heredity. Hereditas, 35(Suppl), 267-273.
9. Haldane, J.B.S. (1949) Disease and evolution. Ric. Sci., A(Suppl), 68-76.
10. Lederberg, J. (1999) Haldane J.B.S. (1949) on infectious disease and evolution. Genetics, 153, 1-3.
11. Beutler, E. (2001) The sickle cell diseases and related disorders. In Beutler, E., Lichtman, M.A., Culler, B.S., Kipps, T.J. and Seligsohn, U. (eds), Williams Hematology, 6th edn. McGraw-Hill, New York, pp. 581-605.
12. Allison, A.C. (1954) Protection afforded by sickle-cell trait against subtertian malarial infection. BMJ, 1, 290-294.
13. Pasvol, G., Weatherall, D.J. and Wilson, R.J. (1978) Cellular mechanism for the protective effect of haemoglobin S against R falciparum malaria. Nature, 274, 701-703.
14. Hill, A.V, Allsopp, C.E., Kwiatkowski, D., Anstey, N.M., Twumasi, R, Rowe, P.A., Bennett, S., Brewster, D., McMichael, A.J. and Greenwood, B.M. (1991) Common West African HLA antigens are associated with protection from severe malaria. Nature, 352, 595-600.
15. Chippaux, J.P., Massougbodji, A., Boulard, J.C. and Akogbeto, M. (1992) Morbidity and severity of malaria attacks in carriers of sickle-cell trait. Rev. Epidemiol. Sante Publique, 40, 240-245.
16. Shear, H.L., Roth, E.F., Jr, Fabry, M.E., Costantini, F.D., Pachnis, A., Hood, A. and Nagel, R.L. (1993) Transgenic mice expressing human sickle hemoglobin are partially resistant to rodent malaria. Blood, 81, 222-226.
17. Modiano, D., Luoni, G., Sirima, B.S., Simpore, J., Verra, E, Konate, A., Rastrelli, E., Olivieri, A., Calissano, C., Paganotti, G.M. et al. (2001) Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature, 414, 305-308.
18. Hutagalung, R., Wilairatana, P, Looareesuwan, S., Brittenham, G.M., Aikawa, M. and Gordeuk, V.R. (1999) Influence of hemoglobin E trait on the severity of Falciparum malaria. J. Infect. Dis., 179, 283-286.
19. Weatherall, D.J. (2001) The thalassemias. In Beutler, E., Lichtman, M.A., Coller, B.S., Kipps, T.J. and Seligsohn, U. (eds), Williams Hematology, 6th edn. McGraw-Hill, New York, pp. 547-580.
20. Willcox, M., Bjorkman, A., Brohult, J., Pehrson, P.O., Rombo, L. and Bengtsson, E. (1983) A case-control study in northern Liberia of Plasmodium falciparum malaria in haemoglobin S and β-thalassaemia traits. Ann. Trop. Med. Parasitol., 77, 239-246.
21. Flint, J., Hill, A.V., Bowden, D.K., Oppenheimer, S.J., Sill, P.R., Serjeantson, S.W., Bana-Koiri, J., Bhatia, K., Alpers, M.P., Boyce, A.J. et al. (1986) High frequencies of α-thalassaemia are the result of natural selection by malaria. Nature, 321, 744-750.
22. Williams, T.N., Maitland, K., Bennett, S., Ganczakowski, M., Pero, T.E., Newbold, C.I., Bowden, D.K., Weatherall, D.J. and Clegg, J.B. (1996) High incidence of malaria in α-thalassaemic children. Nature, 383, 522-525.
23. +-Thalassemia protects children against disease caused by other infections as well as malaria. Proc. Natl Acad. Sci. USA, 94, 14736-14741.
24. Luzzi, G.A., Merry, A.H., Newbold, C.I., Marsh, K., Pasvol, G. and Weatherall, D.J. (1991) Surface antigen expression on Plasmodium falciparum-infected erythrocytes is modified in α- and β-thalassemia. J Exp. Med., 173, 785-791.
25. Carlson, J., Nash, G.B., Gabutti, V., al-Yaman, F. and Wahlgren, M. (1994) Natural protection against severe Plasmodium falciparum malaria due to impaired rosette formation. Blood, 84, 3909-3914.
26. Yuthavong, Y., Bunyaratvej, A. and Kamchonwongpaisan, S. (1990) Increased susceptibility of malaria-infected variant erythrocytes to the mononuclear phagocyte system. Blood Cells, 16, 591-597.
27. Schofield, A.E., Reardon, D.M. and Tanner, M.J. (1992) Defective anion transport activity of the abnormal band 3 in hereditary ovalocytic red blood cells. Nature, 355, 836-838.
28. Kidson, C., Lamont, G., Saul, A. and Nurse, G.T. (1981) Ovalocytic erythrocytes from Melanesians are resistant to invasion by malaria parasites in culture. Proc. Natl Acad. Sci. USA, 78, 5829-5832.
29. Hadley, T., Saul, A., Lamont, G., Hudson, D.E., Miller, L.H. and Kidson, C. (1983) Resistance of Melanesian elliptocytes (ovalocytes) to invasion by Plasmodium knowlesi and Plasmodium falciparum malaria parasites in vitro. J. Clin. Invest., 71, 780-782.
30. Bunyaratvej, A., Butthep, R, Kaewkettong, P. and Yuthavong, Y. (1997) Malaria protection in hereditary ovalocytosis: relation to red cell deformability, red cell parameters and degree of ovalocytosis. Southeast Asian J. Trop. Med. Public Health, 28, 38-42.
31. Cattani, J.A., Gibson, E.D., Alpers, M.P. and Crane, G.G. (1987) Hereditary ovalocytosis and reduced susceptibility to malaria in Papua New Guinea. Trans. R. Soc. Trop. Med. Hyg., 81, 705-709.
32. Mgone, C.S., Koki, G., Paniu, M.M., Kono, J., Bhatia, K.K., Genton, B., Alexander, N.D. and Alpers, M.P. (1996) Occurrence of the erythrocyte band 3 (AE1) gene deletion in relation to malaria endemicity in Papua New Guinea. Trans. R. Soc. Trop. Med. Hyg., 90, 228-231.
33. Allen, S.J, O'Donnell, A., Alexander, N.D., Mgone, C.S., Pero, T.E., Clegg, J.B., Alpers, M.P. and Weatherall, D.J. (1999) Prevention of cerebral malaria in children in Papua New Guinea by Southeast Asian ovalocytosis band 3. Am. J. Trop. Med. Hyg., 60, 1056-1060.
34. Patel, S.S., Mehlotra, R.K., Kastens, W., Mgone, C.S., Kazura, J.W. and Zimmerman, P.A. (2001) The association of the glycophorin C exon 3 deletion with ovalocytosis and malaria susceptibility in the Wosera, Papua New Guinea. Blood, 98, 3489-3491.
35. Ruwende, C., Khoo, S.C., Snow, R.W., Yates, S.N., Kwiatkowski, D., Gupta, S., Warn, R, Allsopp, C.E., Gilbert, S.C., Peschu, N. and et al. (1995) Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature, 376, 246-249.
36. Ruwende, C. and Hill, A. (1998) Glucose-6-phosphate dehydrogenase deficiency and malaria. J. Mol. Med., 76, 581-588.
37. Friedman, M.J. (1979) Oxidant damage mediates variant red cell resistance to malaria. Nature, 280, 245-247.
38. Cappadoro, M., Giribaldi, G., O'Brien, E., Turrini, F., Mannu, F., Ulliers, D., Simula, G., Luzzatto, L. and Arese, P. (1998) Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood, 92, 2527-2534.
39. Miller, L.H., Mason, S.J., Clyde, D.F. and McGinniss, M.H. (1976) The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N. Engl. J. Med., 295, 302-304.
40. Barnwell, J.W., Nichols, M.E. and Rubinstein, P. (1989) In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax. J. Exp. Med., 169, 1795-1802.
41. Horuk, R., Chitnis, C.E., Darbonne, W.C., Colby, T.J., Rybicki, A., Hadley, T.J. and Miller, L.H. (1993) A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science, 261, 1182-1184.
42. Tournamille, C., Colin, Y., Cartron, J.P. and Le Van Kim, C. (1995) Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat. Genet., 10, 224-228.
43. Modiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Diallo, D., Esposito, F. and Coluzzi, M. (1996) Different response to Plasmodium-falciparum malaria in West Affican sympatric ethnic groups. Proc. Natl Acad. Sci. USA, 93, 13206-13211.
44. Modiano, D., Luoni, G., Sirima, B.S., Lanfrancotti, A., Petrarca, V., Cruciani, E., Simpore, J., Ciminelli, B.M., Foglietta, E., Grisanti, P. et al. (2001) The lower susceptibility to Plasmodium-falciparum malaria of Fulani of Burkina Faso (West Africa) is associated with low frequencies of classic malaria-resistance genes. Trans. R. Soc. Trop. Med. Hyg., 95, 149-152.
45. Luoni, G., Verra, E., Arca, B., Sirima, B.S., Troye-Blomberg, M., Coluzzi, M., Kwiatkowski, D. and Modiano, D. (2001) Antimalarial antibody levels and IL4 polymorphism in the Fulani of West Africa. Genes Immunity, 2, 411-414.
46. Abel, L., Cot, M., Mulder, L., Carnevale, P. and Feingold, J. (1992) Segregation analysis detects a major gene controlling blood infection levels in human malaria. Am. J. Hum. Genet., 50, 1308-1317.
47. Garcia, A., Cot, M., Chippaux, J.P., Ranque, S., Feingold, J., Demenais, F. and Abel, L. (1998) Genetic control of blood infection levels in human malaria: evidence for a complex genetic model. Am. J. Trop. Med. Hyg., 58, 480-488.
48. Rihet, P, Abel, L., Traore, Y., Traore-Leroux, T., Aucan, C. and Fumoux, F. (1998) Human malaria: segregation analysis of blood infection levels in a suburban area and a rural area in Burkina Faso. Genet. Epidemiol., 15, 435-450.
49. Garcia, A., Marquet, S., Bucheton, B., Hillaire, D., Cot, M., Fievet, N., Dessein, A.J. and Abel, L. (1998) Linkage analysis of blood Plasmodium falciparum levels: interest of the 5q31-q33 chromosome region. Am. J. Trop. Med. Hyg., 58, 705-709.
50. Marquet, S., Abel, L., Hillaire, D., Dessein, H., Kalil, J., Feingold, J., Weissenbach, J. and Dessein, A.J. (1996) Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q3l-q33. Nat. Genet., 14, 181-184.
51. Rihet, R, Traore, Y., Abel, L., Aucan, C., Traore-Leroux, T. and Fumoux, F. (1998) Malaria in humans: Plasmodium falciparum blood infection levels are linked to chromosome 5q31-q33. Am. J. Hum. Genet., 63, 498-505.
52. Holloway, J.W., Lonjou, C., Beghe, B., Peng, Q., Gaunt, T.R., Gomes, I., Hall, I.P., Dewar, J.C., Wilkinson, J., Thomas, N.S., et al. (2001) Linkage analysis of the 5q31-33 candidate region for asthma in 240 UK families. Genes Immunity, 2, 20-24.
53. Jacobs, K.B., Burton, P.R., Iyengar, S.K., Elston, R.C. and Palmer, L.J. (2001) Pooling data and linkage analysis in the chromosome 5q candidate region for asthma. Genet. Epidemiol., 21, S103-S108.
54. Jepson, A.P., Banya, W.A., Sisay-Joof, F., Hassan-King, M., Bennett, S. and Whittle, H.C. (1995) Genetic regulation of fever in Plasmodium-falciparum malaria in Gambian twin children. J. Infect Dis., 172, 316-319.
55. Jepson, A., Sisay-Joof, F., Banya, W., Hassan-King, M., Frodsham, A., Bennett, S., Hill, A.V and Whittle, H. (1997) Genetic linkage of mild malaria to the major histocompatibility complex in Gambian children: study of affected sibling pairs. BMJ, 315, 96-97.
56. Jepson, A., Banya, W., Sisay-Joof, F., Hassan-King, M., Nunes, C., Bennett, S. and Whittle, H. (1997) Quantification of the relative contribution of major histocompatibility complex (MHC) and non-MHC genes to human immune responses to foreign antigens. Infect. Immunity, 65, 872-876.
57. Sjoberg, K., Lepers, J.P., Raharimalala, L., Larsson, A., Olerup, O., Marbiah, N.T., Troye-Blomberg, M. and Perlmann, P. (1992) Genetic regulation of human anti-malarial antibodies in twins. Proc. Natl Acad. Sci. USA, 89, 2101-2104.
58. Aucan, C., Traore, Y., Fumoux, F. and Rihet, P. (2001) Familial correlation of immunoglobulin G subclass responses to Plasmodium-falciparum antigens in Burkina Faso. Infect. Immunity, 69, 996-1001.
59. Stirnadel, H.A., Beck, H.P., Alpers, M.P. and Smith, T.A. (1999) Heritability and segregation analysis of immune responses to specific malaria antigens in Papua New Guinea. Genet. Epidemiol., 17, 16-34.
60. McGuire, W., Hill, A.V., Allsopp, C.E., Greenwood, B.M. and Kwiatkowski, D. (1994) Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature, 371, 508-510.
61. Wilson, A.G., Symons, J.A., McDowell, T.L., McDevitt, H.O. and Duff, G.W. (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl Acad. Sci. USA, 94, 3195-3199.
62. McGuire, W., Knight, J.C., Hill, A.V., Allsopp, C.E., Greenwood, B.M. and Kwiatkowski, D. (1999) Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J. Infect. Dis., 179, 287-290.
63. Knight, J.C., Udalova, I., Hill, A.V, Greenwood, B.M., Peshu, N., Marsh, K. and Kwiatkowski, D. (1999) A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat. Genet., 22, 145-150.
64. Hill, A.V, Elvin, J., Willis, A.C., Aidoo, M., Allsopp, C.E., Gotch, E.M., Gao, X.M., Takiguchi, M., Greenwood, B.M., Townsend A.R. et al. (1992) Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature, 360, 434-439.
65. Fernandez-Reyes, D., Craig, A.G., Kyes, S.A., Peshu, N., Snow, R.W., Berendt, A.R., Marsh, K. and Newbold, C.I. (1997) A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Hum. Mol. Genet., 6, 1357-1360.
66. Kun, J.F., Klabunde, J., Lell, B., Luckner, D., Alpers, M., May, J., Meyer, C. and Kremsner, P.G. (1999) Association of the ICAM-1Kilifi mutation with protection against severe malaria in Lambarene, Gabon. Am. J. Trop. Med. Hyg., 61, 776-779.
67. Bellamy, R., Kwiatkowski, D. and Hill, A.V. (1998) Absence of an association between intercellular adhesion molecule 1, complement receptor 1 and interleukin 1 receptor antagonist gene polymorphisms and severe malaria in a West African population. Trans. R. Soc. Trop. Med. Hyg., 92, 312-316.
68. Craig, A., Fernandez-Reyes, D., Mesri, M., McDowall, A., Altieri, D.C., Hogg, N. and Newbold, C. (2000) A functional analysis of a natural variant of intercellular adhesion molecule-1 (ICAM-1 Kilifi). Hum. Mol. Genet., 9, 525-530.
69. Kun, J.F., Mordmuller, B., Lell, B., Lehman, L.G., Luckner, D. and Kremsner, P.G. (1998) Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet, 351, 265-266.
70. Burgner, D., Xu, W., Rockett, K., Gravenor, M., Charles, I.G., Hill, A.V. and Kwiatkowski, D. (1998) Inducible nitric oxide synthase polymorphism and fatal cerebral malaria. Lancet, 352, 1193-1194.
71. Levesque, M.C., Hobbs, M.R., Anstey, N.M., Vaughn, T.N., Chancellor, J.A., Pole, A., Perkins, D.J., Misukonis, M.A., Chanock, S.J., Granger, D.L. and Weinberg, J.B. (1999) Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria. J. Infect. Dis., 180, 1994-2002.
72. Urban, B.C., Ferguson, D.J., Pain, A., Willcox, N., Plebanski, M., Austyn, J.M. and Roberts, D.J. (1999) Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature, 400, 73-77.
73. Urban, B.C., Willcox, N. and Roberts, D.J. (2001) A role for CD36 in the regulation of dendritic cell function. Proc. Natl Acad. Sci. USA, 98, 8750-8755.
74. McGilvray, I.D., Serghides, L., Kapus, A., Rotstein, O.D. and Kain, K.C. (2000) Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum-parasitized erythrocytes: a role for CD36 in malarial clearance. Blood, 96, 3231-3240.
75. Pain, A., Ferguson, D.J., Kai, O., Urban, B.C., Lowe, B., Marsh, K. and Roberts, D.J. (2001) Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria. Proc. Natl Acad. Sci. USA, 98, 1805-1810.
76. Aitman, T.J., Cooper, L.D., Norsworthy, P.J., Wahid, E.N., Gray, J.K., Curtis, B.R., McKeigue, P.M., Kwiatkowski, D., Greenwood, B.M., Snow, R.W. et al. (2000) Malaria susceptibility and CD36 mutation. Nature, 405, 1015-1016.
77. Gelhaus, A., Scheding, A., Browne, E., Burchard, G.D. and Horstmann, R.D. (2001) Variability of the CD36 gene in West Africa. Hum. Mutat., 18, 444-450.
78. Pain, A., Urban, B.C., Kai, O., Casals-Pascual, C., Shafi, J., Marsh, K. and Roberts, D.J. (2001) A non-sense mutation in Cd36 gene is associated with protection from severe malaria. Lancet, 357, 1502-1503.
79. Vidal, S.M., Malo, D., Vogan, K., Skamene, E. and Gros, P. (1993) Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell, 73, 469-485.
80. Poltorak, A., He, X., Smirnova, I., Liu, M.Y., Huffel, C.V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C. et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science, 282, 2085-2088.
81. Qureshi, S.T., Lariviere, L., Leveque, G., Clermont, S., Moore, K.J., Gros, P. and Malo, D. (1999) Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med., 189, 615-625.
82. Lee, S.H., Girard, S., Macina, D., Busa, M., Zafer, A., Belouchi, A., Gros, P. and Vidal, S.M. (2001) Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet., 28, 42-45.
83. Brown, M.G., Dokun, A.O., Heusel, J.W., Smith, H.R., Beckman, D.L., Blattenberger, E.A., Dubbelde, C.E., Stone, L.R., Scalzo, A.A. and Yokoyama, W.M. (2001) Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science, 292, 934-937.
84. Landau, I., Gautret, P. (1998) Animal models: rodents. In Sherman, I.W. (ed.), Malaria, Parasite Biology, Pathogenesis, and Protection. ASM Press, Washington, DC, pp. 401-417.
85. Taylor-Robinson, A.W., and Smith, E.C. (1999) A role for cytokines in potentiation of malaria vaccines through immunological modulation of blood stage infection. Immunol. Rev., 171, 105-123.
86. Cox, J., Semoff, S. and Hommel, M. (1987) Plasmodium chabaudi: a rodent malaria model for in-vivo and in-vitro cytoadherence of malaria parasites in the absence of knobs. Parasite Immunol., 9, 543-561.
87. Eugui, E.M. and Allison, A.C. (1980) Differences in susceptibility of various mouse strains to haemoprotozoan infections: possible correlation with natural killer activity. Parasite Immunol., 2, 277-292.
88. Stevenson, M.M., Lyanga, J.J. and Skamene, E. (1982) Murine malaria: genetic control of resistance to Plasmodium chabaudi. Infect. Immunity, 38, 80-88.
89. Fortin, A., Stevenson, M.M. and Gros, P. (2002) Complex genetic control of susceptibility to malaria in mice. Genes Immunity, 3, 177-186.
90. Bagot, S., Idrissa Boubou, M., Campino, S., Behrschmidt, C., Gorgette, O., Guenet, J.L., Penha-Goncalves, C., Mazier, D., Pied, S. and Cazenave, P.A. (2002) Susceptibility to experimental cerebral malaria induced by Plasmodium berghei ANKA in inbred mouse strains recently derived from wild stock. Infect. Immunity, 70, 2049-2056.
91. Nagayasu, E., Nagakura, K., Akaki, M., Tamiya, G., Makino, S., Nakano, Y., Kimura, M. and Aikawa, M. (2002) Association of a determinant on mouse chromosome 18 with experimental severe Plasmodium berghei malaria. Infect. Immunity, 70, 512-516.
92. Stevenson, M.M., Tam, M.F. and Rae, D. (1990) Dependence on cell-mediated mechanisms for the appearance of crisis forms during Plasmodium chabaudi AS infection in C57BL/6 mice. Microb. Pathog., 9, 303-314.
93. + T cells and B cells are necessary for the transfer of protective immunity to Plasmodium chabaudi chabaudi. Eur. J. Immunol., 21, 1433-1438.
94. + T lymphocytes both contribute to acquired immunity to blood-stage Plasmodium chabaudi AS. Infect. Immunity, 59, 51-58.
95. - and CD8-bearing T lymphocytes in the immune response to the erythrocytic stages of Plasmodium chabaudi. Infect. Immunity, 56, 3081-3088.
96. + T cells to Plasmodium chabaudi chabaudi. Immunol. Rev., 112, 71-94.
97. Stevenson, M.M., Ghadirian, E., Phillips, N.C., Rae, D. and Podoba, J.E. (1989) Role of mononuclear phagocytes in elimination of Plasmodium chabaudi AS infection. Parasite Immunol., 11, 529-544.
98. Sam, H., Su, Z. and Stevenson, M.M. (1999) Deficiency in tumor necrosis factor alpha activity does not impair early protective Th1 responses against blood-stage malaria. Infect. Immunity, 67, 2660-2664.
99. van der Heyde, H.C., Gu, Y., Zhang, Q., Sun, G. and Grisham, M.B. (2000) Nitric oxide is neither necessary nor sufficient for resolution of Plasmodium chabaudi malaria in mice. J. Immunol., 165, 3317-3323.
100. Von der Weid, T., Kopf, M., Köhler, G. and Langhorne, J. (1994) The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. Eur. J. Immunol., 24, 2285-2293.
101. Linke, A., Kuhn, R., Muller, W., Honarvar, N., Li, C. and Langhorne, J. (1996) Plasmodium chabaudi chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection. Exp. Parasitol., 84, 253-263.
102. Riopel, J., Tam, M., Mohan, K., Marino, M.W. and Stevenson, M.M. (2001) Granulocyte macrophage colony-stimulating factor-deficient mice have impaired resistance to blood-stage malaria. Infect. Immunity, 69, 129-136.
103. Su, Z. and Stevenson, M.M. (2000) Central role of endogenous γ interferon in protective immunity against blood-stage Plasmodium chabaudi AS infection. Infect. Immunity, 68, 4399-4406.
104. Su, Z. and Stevenson, M.M. (2002) IL-12 is required for antibodymediated protective immunity against blood-stage Plasmodium chabaudi AS malaria infection in mice. J. Immunol., 168, 1348-1355.
105. Nogami, S., Watanabe, J., Nakagaki, K., Nakata, K., Suzuki, H., Fujisawa, M., Kodama, T. and Kojima, S. (1998) Involvement of macrophage scavenger receptors in protection against murine malaria. Am. J. Trop. Med. Hyg., 59, 843-845.
106. Foote, S.J., Burt, R.A., Baldwin, T.M., Presente, A., Roberts, A.W., Laural, Y.L., Lew, A.M. and Marshall, V.M. (1997) Mouse loci for malaria-induced mortality and the control of parasitaemia. Nat. Genet., 17, 380-381.
107. Fortin, A., Belouchi, A., Tam, M.F., Cardon, L., Skamene, E., Stevenson, M.M. and Gros, P. (1997) Genetic control of blood parasitaemia in mouse malaria maps to chromosome 8. Nat. Genet., 17, 382-383.
108. Wunderlich, F., Mossmann, H., Helwig, M. and Schillinger, G. (1988) Resistance to Plasmodium chabaudi in B10 mice: influence of the H-2 complex and testosterone. Infect. Immunity, 56, 2400-2406.
109. Ohno, T., Ishih, A., Kohara, Y., Yonekawa, H., Terada, M. and Nishimura, M. (2001) Chromosomal mapping of the host resistance locus to rodent malaria (Plasmodium yoelii) infection in mice. Immunogenetics, 53, 736-740.
110. Stevenson, M.M. and Tam, M.F. (1993) Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible mice. Clin. Exp. Immunol., 92, 77-83.
111. Jacobs, P., Radzioch, D. and Stevenson, M.M. (1996) A Th1-associated increase in tumor necrosis factor a expression in the spleen correlates with resistance to blood-stage malaria in mice. Infect. Immunity, 64, 535-541.
112. www.jax.org.
113. Burt, R.A., Baldwin, T.M., Marshall, V.M. and Foote, S.J. (1999) Temporal expression of an H2-linked locus in host response to mouse malaria. Immunogenetics, 50, 278-285.
114. Flint, J. and Mott, R. (2001) Finding the molecular basis of quantitative traits: successes and pitfalls. Nat. Rev. Genet., 2, 437-445.
115. Fortin, A., Penman, M., Stevenson, M.M., Krieger, M. and Gros, P. (2000) Identification and characterization of naturally occurring variants of the macrophage scavenger receptor (SR-A). Mamm. Genome, 11, 779-785.
116. Daugherty, A., Whitman, S.C., Block, A.E. and Rateri, D.L. (2000) Polymorphism of class A scavenger receptors in C57BL/6 mice. J. Lipid Res., 41, 1568-1577.
117. Suzuki, H., Kurihara, Y, Takeya, M., Kamada, N., Kataoka, M., Jishage, K., Ueda, O., Sakaguchi, H., Higashi, T., Suzuki, T. et al. (1997) A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature, 386, 292-296.
118. Fortin, A., Diez, E., Rochefort, D., Laroche, L., Malo, D., Rouleau, G.A., Gros, P. and Skamene, E. (2001) Recombinant congenic strains derived from A/J and C57BL/6J: a tool for genetic dissection of complex traits. Genomics, 74, 21-35.
119. Castellani, L.W., Weinreb, A., Bodnar, J., Goto, A.M., Doolittle, M., Mehrabian, M., Demant, P. and Lusis, A.J. (1998) Mapping a gene for combined hyperlipidaemia in a mutant mouse strain. Nat. Genet., 18, 374-377.
120. Fijneman, R.J., de Vries, S.S., Jansen, R.C. and Demant, P. (1996) Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nat. Genet., 14, 465-467.
121. Krulova, M., Havelkova, H., Kosarova, M., Holan, V, Hart, A.A., Demant, P. and Lipoldova, M. (1997) IL-2-induced proliferative response is controlled by loci Cinda1 and Cinda2 on mouse chromosomes 11 and 12: a distinct control of the response induced by different IL-2 concentrations. Genomics, 42, 11-5.
122. Lipoldova, M., Svobodova, M., Krulova, M., Havelkova, H., Badalova, J., Nohynkova, E., Holan, V, Hart, A.A.M., Volf, P. and Demant, P. (2000) Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes. Genes Immunity, 1, 170-206.
123. van Wezel, T., Stassen, A.R, Moen, C.J., Hart, A.A., van der Valk, M.A. and Demant, P. (1996) Gene interaction and single gene effects in colon tumour susceptibility in mice. Nat. Genet., 14, 468-470.
124. Fortin, A., Carden, L.R., Tam, M., Skamene, E., Stevenson, M.M. and Gros, P. (2001) Identification of a new malaria susceptibility locus (Char4) in recombinant congenic strains of mice. Proc. Natl Acad. Sci. USA, 98, 10793-10798.